Influenza A virus A/Switzerland/9715293/2013 (H3N2) live (attenuated) antigen Withdrawn Phase 1 Trials for Influenza, Human Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT02950688Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus